Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IMIGLUCERASE vs IMIQUIMOD: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IMIGLUCERASE vs IMIQUIMOD: Safety Overview

Metric IMIGLUCERASE IMIQUIMOD
Total FAERS Reports 2,564 1,689
Deaths Reported 322 25
Death Rate 12.6% 1.5%
Hospitalizations 549 154
Average Patient Age 36.4 yrs 62.3 yrs
% Female Patients 62.7% 52.1%
FDA Approval Date N/A Apr 15, 2011
Manufacturer Genzyme Corporation Padagis Israel Pharmaceuticals Ltd
Route INTRAVENOUS TOPICAL
Marketing Status Prescription Discontinued